Arcturus therapeutics to present at the 41st annual j.p. morgan healthcare conference

San diego--( business wire )--arcturus therapeutics holdings inc. (the “company”, “arcturus”, nasdaq: arct), a global late-stage clinical messenger rna medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today announced that the company will present at the annual j.p. morgan healthcare conference in san francisco, on wednesday, january 11, 2023, at 9:00 a.m. pacific time.
ARCT Ratings Summary
ARCT Quant Ranking